Tim Wither – Managing Director – Maximus Resources (ASX:MXR) is a gold and nickel exploration company.
Copyright 2023 – Finance News Network
Source: Finance News Network
18 Nov 2020 - Shaw and Partners Chief Investment Officer Martin Crabb discusses to the current economic climate, inflation, and government and central bank reactions.
Read More11 Jun 2024 - Glen Finegan, Lead Portfolio Manager of Skerryvore, discusses the company's bottom-up approach to investing in emerging markets, emphasising governance, pricing power, and diversification as key drivers of success.
Read More25 May 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the paradox of rising valuations in a looming bear market.
Read More29 Mar 2021 - Telix Pharmaceuticals Limited (ASX:TLX) Chief Business Officer Dr David Cade talks about the company's clinical programs, including approvals, partnerships and significant value events anticipated in 2021.
Read More28 Sep 2022 - Meeka Metals Limited (ASX:MEK) Managing Director and CEO Tim Davidson discusses recent gold and rare earths results and the outlook for the next year.
Read More25 May 2021 - Skyfii Limited (ASX:SKF) CEO & Managing Director Wayne Arthur talks about the company's SaaS cloud-based solution that helps venues visualise, measure, predict and influence customer behaviour, creating better experiences for their visitors and customers.
Read More07 Jul 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company's portfolio of therapies.
Read More16 Aug 2023 - Sam Budiselik - Managing Director - Cash Converters (ASX:CCV) is a diverse group generating revenues from franchising, store operations, personal and vehicle finance.
Read More05 Aug 2024 - BlinkLab Limited (ASX:BB1) Non-Executive Chairman Brian Leedman discusses transforming smartphones into diagnostic tools.
Read More01 Jun 2020 - OncoSil Medical Limited (ASX:OSL) Managing Director and CEO Daniel Kenny talks about the significance of the company's CE Marking approval for its lead product OncoSil, which helps treat pancreatic, liver and biliary duct cancer.
Read More
